Robert John
Fortune : 50 694 $ au 31/07/2026
Fortune : 50 694 $ au 31/07/2026
Robert John worked at Abbott Laboratories from 2008 to 2023 as General Manager-Cardiac Rhythm Management EMEA. Mr. John worked at CVRx, Inc. from 2024 to 2026 as Chief Revenue Officer.
Mr. John completed undergraduate studies at the University of North Texas and graduate studies at The University of Alabama.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CVRX, INC. 0,04 % | 06/04/2026 | 9 796 ( 0,04 % ) | 50 694 $ | 31/07/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| CVRX, INC. | Corporate Officer/Principal | 10/08/2026 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01/01/2023 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
The University of Alabama
The University of Alabama Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of North Texas
University of North Texas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CVRx, Inc.
CVRx, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes neuromodulation device & implantable technology to treat hypertension and heart failure | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national